Hydrogenology
Source-linked study record

Brain Metastases Completely Disappear in Non-Small Cell Lung Cancer Using Hydrogen Gas Inhalation: A Case Report

Chen J, Mu F, Lu T, Du D, Xu K. · OncoTargets and therapy. 2019;12:11145-11151.

HumanInhaled H₂Published 2019Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Human

Population or model

Human participants studied for respiratory health. See eligibility criteria in the linked full text.

Intervention and dose

Full text reports inhaled H₂-containing gas. Detected intervention quantities or schedules: 6 hrs, 4 months, 3 L/min, 67%, 33%. · H₂-related quantities reported in the intervention passages: 6 hrs, 4 months, 3 L/min, 67%, 33%. Values are not combined across different experimental arms.

Duration

6 hrs

Reported result

Article-reported result excerpt (24 words maximum): “There were increased levels of carcinoembryonic antigen (CEA, 29.44 ng/mL), carbohydrate antigen-125 (CA125, 153 U/mL) and cytokeratin fragment antigen21-1 (CYFRA21-1, 12.1 ng/mL) before the…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Main limitation

Human evidence; design, sample size and comparator limit interpretation. No funding statement was identified in the machine-readable full article; absence is not inferred. The article declares no conflicts of interest.

Evidence and classification

What kind of evidence is this?

Evidence type

Human

Reported design

Case report

Research topic

Respiratory health

Administration form

Inhaled H₂

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Human participants studied for respiratory health. See eligibility criteria in the linked full text.

Sample

Human study; the article does not state one consolidated sample total, so no total is inferred.

Duration

6 hrs

Intervention

Full text reports inhaled H₂-containing gas. Detected intervention quantities or schedules: 6 hrs, 4 months, 3 L/min, 67%, 33%.

Hydrogen form

Brown’s gas / oxyhydrogen — H₂ and O₂ co-delivered, not H₂ alone.

Dose or H₂ specification

H₂-related quantities reported in the intervention passages: 6 hrs, 4 months, 3 L/min, 67%, 33%. Values are not combined across different experimental arms.

H₂ flow

2010 mL/min H₂, calculated from 67% H₂ and 3000 mL/min total flow reported in the full text.

O₂ delivered with H₂

33% O₂; 990 mL/min O₂ calculated from the reported total flow.

Comparator

Control or comparison condition reported in the full article; see the linked methods for arm-specific details.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

survival or mortality, tumor growth or cancer markers, inflammation and cytokines, oxidative-stress and antioxidant markers, apoptosis or cell injury, histology or tissue damage

Reported result

Article-reported result excerpt (24 words maximum): “There were increased levels of carcinoembryonic antigen (CEA, 29.44 ng/mL), carbohydrate antigen-125 (CA125, 153 U/mL) and cytokeratin fragment antigen21-1 (CYFRA21-1, 12.1 ng/mL) before the…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Extraction completeness

The complete machine-readable article was checked for source identity, methods, intervention quantities, results, tables, funding and conflict declarations. This public record is based on the full article.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Human evidence; design, sample size and comparator limit interpretation. No funding statement was identified in the machine-readable full article; absence is not inferred. The article declares no conflicts of interest.

Applies directly to

Applies only to the population and protocol reported in this respiratory health article.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 31908482 · DOI: 10.2147/ott.s235195

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official PubMed/PMC full article; source identity, intervention data and declarations re-audited 25 August 2026.

Last reviewed

25 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.